Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer shows a new revision label: v3.6.6 replaced v3.6.5. This reflects a minor template or system update that does not alter the study details or documented content.
    Difference
    0.0%
    Check dated 2026-08-30T15:45:43.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the page. This indicates a newer version of the page has been published.
    Difference
    0.0%
    Check dated 2026-08-09T09:13:07.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor update to the study record. This metadata change does not alter the study data, endpoints, or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-07-25T17:55:54.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a new page release or patch. It represents a version change rather than a substantive change to the content.
    Difference
    0.0%
    Check dated 2026-07-04T04:33:06.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, indicating a minor backend/template update. This change does not modify study details, eligibility criteria, or results shown on the page.
    Difference
    0.0%
    Check dated 2026-06-27T03:13:52.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and metadata labels (Last verified, Last known status was) were introduced. A site revision update (Revision: v3.6.0) and a minor formatting change to the Intervention/Treatment heading were also applied.
    Difference
    1%
    Check dated 2026-06-12T17:21:43.000Z thumbnail image

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.